The economic burden of major adult visual disorders in the United States.

By David B. Rein, Ping Zhang, K. Wirth, Paul P. Lee, T. Hoerger, N. McCall, Ronald Klein, J. Tielsch, S. Vijan, J. Saaddine. A M A Archives of Ophthalmology, 2006

646 citations recorded by the source corpus.

Subfields: Epidemiology, Ophthalmology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/b23033c87b397a25f5afaaa205ee51372868e0dc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Yingfeng Zheng
2. M. He
3. N. Congdon
4. I. Morgan

Citations in the corpus

• The worldwide epidemic of diabetic retinopathy (2012, background): “[23] In the United States alone, the direct annual costs of DR were estimated to be USD$490 million in 2004.[24] In Sweden, the annual average healthcare cost of any DR, PDR, and DME amounts to USD$93.”
• Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. (2009, neutral): “If 25% of those aged 12 to 54 years had myopia, the associated annual cost would be more than $2 billion 31,32 ; an increase in prevalence to 37% would increase the cost to more than $3 billion.”